An uclear receptor, peroxisome proliferator-activated receptor g (PPARg ), is al igand-dependent transcription factor involved in glucose homeostasis anda dipocyted ifferentiation. PPARg is the molecular target of various natural ands ynthetic molecules, includinga nti-diabetic agents such as rosiglitazone. Amide hydrogen/deuterium-exchange (H/D-Ex), coupled with proteolysis and mass spectrometry,w as applied to study the dynamics of theP PAR g ligand binding domain (LBD) with or withoutmolecules that modulate PPARg activity.The H/D-Ex patterns of ligand-free PPARg LBD show that the ligand binding pocket of LBD is significantly more dynamic than ther est of the LBD. Presumably,t he bindingp ocketi si ntrinsically disordered in order to accommodated ifferentl igands. The presence of twof ull agonists (rosiglitazone and GW1929), ap artial agonist (nTZDpa), and ac ovalenta ntagonist (GW9662), changedt he dynamics/conformation of PPARg LBD ands lowedt he H/D exchanger ate in variousr egionso ft he protein.T he full agonists slowed theH /D exchange more globally andtoagreater extent than the partial agonist or the antagonist, indicating thatthe full agonist stabilizes the PPARg LBDmorethan thepartial agonist or the antagonist. Oneinteresting observation is that thetwo fullagonists significantly stabilized helix12whilethe partial agonist andthe antagonist did not perturb the H/D exchange of this region. Ther esults showedt hatt he change in proteind ynamics induced by ligandb inding may be an important factor fort he activation of genes and that H/D-Ex is au sefulm ethodf or analyzingt he biological activity of drug leads.
;N agya nd Schwabe2 004; Schwabea nd Teichmann 2004). Consequently,t he NRsc onstitute aw ell-established classo fd rugt argets fort he treatmento fd iseasesa rising from imbalances in cellular differentiationa nd metabolism (Olefsky andS altiel 2000; S altiel 2001) .
NRs bind to DNAashetero-or homodimers and, in associationwithv arious cofactors, regulate gene transcription. Many biochemical and biophysical studies on this class of receptorssuggest that agonists or antagonistsbinding induce conformational changesinthe ligand bindingdomain(LBD) (Brzozowski et al.1997; Pike et al.1999; Johnsonetal. 2000; Bergere ta l. 2003; Kallenbergere ta l. 2003) . Thesec onformational changeshavebeen proposed to play akey role in the biological responses of nuclear receptors (Bergeretal. 2003) .
Peroxisome proliferator-activated receptors (PPARs) are members of theN Rs uperfamily ands ervea sk ey regulators of dietary fats. PPAR forms aheterodimerwith retinoid Xreceptor (RXR) (Gampe et al.2000; Y ang et al. 2000) . Uponb inding to fatty acidsa nd other ligands, the heterodimer bindsD NA to regulate thee xpressiono f genesf or thet ransport andm etabolismo ft hese molecules. PPARg playsam ajor role in ther egulationo fg lucose and lipidh omeostasis andi st he moleculart argetf or thea ntidiabetic agentr osiglitazone (Willson et al.2 000) .
Amide hydrogen/deuteriume xchange( H/D-Ex),c oupled with proteolysisand liquid chromatography-massspectrometry analysis (LC-MS), is am ethodt hath as recently gained in sophistication andh as been used increasingly in theanalysisofprotein structure/dynamics (Engen andSmith 2001; H oofnagle et al.2 001; Hamuro et al. 2003) , proteinproteini nteractions (Ehring 1999; Baerga-Ortiz et al. 2002) , and protein-ligand interactions (Engen and Smith 2001; Hamuroetal. 2002; Englander et al. 2003; Davidson et al. 2004; Yane ta l. 2004 ). Briefly,t he H/D-Exr eaction occurs when aprotein(or aprotein-ligandcomplex)ismi xed with ad euterateds olvent andt he amidehydrogeng radually exchanges with bulk deuterium. Thea mide hydrogens in dynamic regions of the protein will exchange faster with bulk deuterium than those in rigid regions.After quenching the exchange reaction with cold acidic buffer,t he partially deuterated protein is digested, and changesi nm olecular weight of each proteolytic peptide causedb yt he exchange of hydrogen with deuterium are measured by LC-MS.
H/D-Ex is av ery sensitive probe of protein conformation/dynamics, as thea mide hydrogen exchanger ate is mostinfluenced by the involvement in hydrogen bonding. Conformational and/or dynamic changes can be sublocalized to the resolution of several amino acids by coupling proteolytic digestion to H/D-Ex.
Here,H /D-Ex was applied to measure the dynamics of PPARg LBD in the presence or the absenceo fv arious biological modulators.Our results showed that in ligandfree form, theP PAR g LBD portion proximal to the binding cavity is more dynamic than the rest of the protein. Also, thep resence of full agonistsr osiglitazone andG W1929 made the LBDs ignificantly less dynamic thana ntagonist GW9662a nd partial agonist nTZDpa.
Results

PPARg LBD proteolytic fragmentation
Prior to H/D-Ex experiments,d igestion conditions that produced PPARg LBD fragmentso fo ptimal size and distributionf or exchange analysis were established( see Materials andMethods). PepsindigestionofPPAR g LBD was carried out by diluting thed euterated sample (1:1.5) with cold quench solution(2Murea,1MTCEP at pH 2.5). Thequenchedsamplewas then passed over an immobilized pepsin column (104-m Lb ed volume)a taflow rate of 200 m L/mina t1°C, with ad igestion time of 31 sec. These conditions generated49peptidescovering98% of theamino acid sequence of PPARg LBD ( Fig.1 ) . Twenty-three of thei dentified peptides that spanned9 7% of thes equence were of high enough quality( high signal/noise)f or H/D-Ex analysis of theP PAR g LBD( Table1 ).
H/D-Ex of ligand-free PPARg LBD
Ligand-free PPARg LBD wasi ncubatedi nd euterated Tris buffer (pH 8.0) for30-10,000 sec at 25 6 1°C. After thei ncubation, the exchange reaction was quenched with 2Murea, 1MTCEP (pH2 .5) at 1°C. As the amide hydrogen exchange reaction at neutral pH is primarily base-catalyzed,l ow temperaturea nd lowp Hs lowd own the exchange rate significantly. However, becauset he digestion andseparationstepsare in an aqueousenvironment, as mall percentage of amide deuterium gradually reverts back to hydrogen. The averaged euterium retention during the analysis wasm easuredt ob e6 8% (see Materials andM ethods).
Thed euteration levelo fl igand-free PPARg LBDa s afunction of incubation time is illustrated in Figure 2 . Each blocki nt he figure represents oneo ft he 23 high-quality peptides,and each blockcontainssix time points ([from top] 30,1 00,3 00,1 000, 3000,a nd 10,000 sec).I nt hisf igure, dynamica nd fast exchanging segments ares hown in red, whileo rdered ands lowe xchangings egmentsa re showni n blue.S lowe xchangingr egions,w here thea verage deuteration levelo ft he aforementioned sixt imep ointsi s< 50%, includes egments2 14-222 (helix 1),3 01-309 (helix 3 9 ), 312-317( helix4 ), 320-327( helix5 ), 333-340( between helices5and6), 404-416(helix9), and434-442 (helix 10). Fast exchanging segments,w here thea verage deuteration leveli s> 90%, include2 40-256 (helix 2 9 ), 259-278( betweenh elices 2 9 and3 ), 281-287( helix3 ), 455-469 (between helices1 1a nd 12), and4 72-477 (helix 12). Finally, some segments exchange at intermediate rates, specifically helices2 ,6 ,7 ,8 ,a nd 11 (see also Table 1 ).
The dynamic properties of theP PAR g LBD became apparent whenthe H/D-Ex results were overlaid onto the three-dimensional X-ray crystal structure of PPARg LBD (Fig. 3A) . TheH /D-Ex resultsv aried greatly between distinct regions of theL BD domain. Forc larity,t hree subdomains are defined:u pper (H1, H39 ,H 4, H5,b etween H5 andH 6, H9, H10), intermediate (H2, H6, H7, H8,H 11), andl ower (H2 9 ,b etween H29 and H3,H 3, betweenH11 and H12, H12).While theupper subdomain in the LBD ( Fig. 3A) e xchanges slowly,t he intermediate and thel ower subdomainso ft he LBD exchange faster, suggesting that the binding cavity located in the lower subdomaino fL BD is more dynamic than the rest of the domain.T he lowers ubdomain mayb ei ntrinsically disordered to accommodate various ligands (Wright and Dyson1 999) . This observation is consistentw ith the crystallographic temperature factora nalysis (Nolte et al. 1998 ; Nagyand Schwabe2004) and theNMR cross-peak analysis (Johnson et al.2 000) . The crystallographic temperature factorso ft he upper subdomain of LBD were lower, while those of the lowers ubdomainw ereh igher (Fig.3 B ; Nolte et al. 1998 ;N agy andS chwabe 2004). Whilethe three-dimensional NMR cross-peaks at the upper subdomain of PPARg LBD were sharp, those at the lower subdomain were broad, indicating averydynamiccharacter for this regiono ft he LBD (Johnson et al. 2000) .
H/D-Exp erturbations of PPARg LBD by various modulators
TheH/D-Experturbations of PPARg LBDinthe presence of variousm odulatorsw erem easured. Them odulatorsu sedi n this studya re antagonist GW9662 (Leesnitzere ta l. 2002), partiala gonist nTZDpa (Bergere ta l. 2003), andt wo full agonists,G W1929( Browne ta l. 1999)a nd rosiglitazone (Nolte et al.1 998) (Fig.4 ) . Allf ourP PAR g LBD-ligand complex solutionsw erea dded to deuterated water, andt he mixturew as incubatedi na na nalogous manner as ligandfree PPARg LBD( seeM aterials andM ethods). Each of the modulators perturbedt he PPARg LBDt oadifferentd egree (Fig.5 ) . Thed arkb luer egions indicate no difference in deuterationw itho rw ithout ligand.T he regions containing ther emainder of thec olor spectrum indicate different degreest ow hich thel igands protectedP PAR g LBDf rom deuteration. Theregions protectedb yrosiglitazone coincide with knownP PAR g LBD-rosiglitazonec ontact residues (Fig.5 ,r ed circles).T he averaged ifferencei nd euteration levels amongs ix time points fore achs egment with each ligand is summarized in Table1 . Twof ull agonists, GW1929 and rosiglitazone, perturbed the H/D-Ex of PPARg LBD broadly and similarly. Both ligands slowed theH/D exchangeo fs egments 281-287( helix 3), 290-298 (helix 3), 333-340 (between helices 5a nd 6),3 43-351 (helix 6), 354-363 (between helices 6a nd 7), 366-370 (helix 7), 373-377( helix 7), 445-452( helix11),and 472-477(helix12).The effect was so broadt hati ta ppeareda si ft he entire bindingc avityb ecame rigidu ponb inding full agonists.
On theo ther hand,t he perturbationsb ya ntagonist (GW9662) or partial agonist (nTZDpa) were more localized.
Figure2. H/D-Ex pattern of PPARg LBD without ligands. Each horizontal color block represents an analyzed peptic peptide, and each block contains six time points ([from top]30, 100, 300, 1000, 3000, and 10,000 sec). The deuteration levelofeach peptide at each time point is color-coded (see bottom right). The first two residues of each peptide lose the deuterium during analysis (Bai et al. 1993) . Therefore, for example, the informationobtained from peptide 184-211 is actually the informationo nr esidues 186-211. This also accounts for the two-residue gaps between peptides. The vertical color blocks at the bottom represent the B -factor of apo PPARg LBD (1PRG) and correspondt ot he same color-coded keya tt he bottom right.
GW9662 slowed the H/D exchange of segments 290-298 (helix 3), 333-340 (between helices5and 6), 343-351 (helix 6), 354-363 (between helices 6and 7), and 373-377 (helix 7). nTZDpa had the narrowest perturbation, only slowing H/D exchange of the segments 281-287( helix3 ), 290-298( helix3 ), and3 43-351 (helix 6).
One striking variation in theH /D exchange of PPARg LBD with these ligands is the perturbationsa tt he Ct erminus. The twof ull agonists slowed exchange at helix 11 (445-451)a nd helix 12 (472-477), while the antagonistand thepartial agonistdid nothaveany effect on theseregions (Figs. 6, 7) .The alignmentofhelix 12 hasbeen implicated to play acriticalroleintranscriptional activation.
All four ligands tested significantlyp erturbed segment 290-298, whichi st he C-terminal half of helix 3. Three ligands-nTZDpa, GW1929,a nd rosiglitazone-also slowed down exchange of segment 281-287covering theother half of helix 3. This peptidewas notobserved in theexperiments with GW9662, duet ot he covalent modification at cysteine 313.
Discussion
Correlation between H/D-Ex results and X-ray B -factor
The rate of amide hydrogen exchange is dependent upon local fluctuations in protein structure (Englander and Kallenbach 1984) . Fort his reason the rate of H/D-Ex is ag ood indicator of regional flexibility withinaprotein. The atomic temperature factor ( B -factor) reflectst he mobility of an atom in an X-ray crystal structure. It is thereforer easonable to expect thatac orrelation between B-factor and rates of H/D-Exs hould exist (Kossiakoff 1982; Zhang et al.1 996) .
In the present studyo nt he dynamics of PPARg LBD, the H/D-Ex protection factor (the retardation of amide hydrogen exchange rate upon folding)f or each segment in ligand-freeP PAR g LBD wasc alculated (see Supplemental Material). The B -factors for main-chain atomsfor both molecules of PPARg LBD in thea symmetric unit (1PRG) were averaged. Thecorrelation between the H/DEx protection factors andt he average B -factorsw as plotted (Fig. 8) .
Therei samoderatec orrelation ( R 2 ¼ 0.69) between thel ogarithm of theH /D-Ex protection factor andt he crystallographic B -factors ( Fig. 8) .T he reasons for this moderate correlation canb ee xplained by oneo rm oreo f thefollowing: (1)H/D-Ex represents protein dynamicsin solution, whereas the B -factorv alues represent dynamics in the solid state. Regions that can move freelyinsolution mayb ec onstrained by contacts withint he crystal lattice.
ForP PAR g LBD, the regions2 40-256, 259-278, 281-287, 290-298, 455-469, and4 72-477h avea verage B -factorsl ower thane xpectedf rom H/D-Ex protection factors,a nd many of theser esidues participate in intermolecular contacts withint he crystal lattice. In general, theP PAR g LBD crystals tructure( 1PRG)h as tight crystal packing (45% solvent content), ands ome regions wouldtherefore be less dynamic than in solution. (2) The H/D-Ext ime windowe mployed was 30-10,000 sec, and there areafews egments forw hich H/D-Exo ccursc ompletelyb efore 30 sec. Thel ack of shorter time points prevents accurate estimation of thee xchange rates in these segments. (3) Ther esolution limito fs tructural dynamics measured by H/D-Ex is af ew aminoa cids, while B -factorso fm oderate-to high-resolution crystal structures attempt to explain the dynamics of individual atoms. Some finer correlation between protectionf actors and B -factors mighth aveb een averaged out due to this difference.D avid Smitha nd colleagues (Zhang et al. 1996) also observed aweak correlation between the logof averagee xchange rates andt he B -factors for rabbit muscle aldolase. Awider time window andh igher resolution data may improvet he correlationa nd/or give ac learer pictureo ft he difference between thet wo observables.
Full agonists stabilizeP PAR g LBD
Thep roteasep rotection analysis (Bergere ta l. 2003) and X-rayc rystallographys tudieso fN Rs revealed that the NRs change their conformations upon binding biological modulators (Nolte et al.1 998) . These results indicated thatt he conformation of NR, especially helix1 2, is critical forg enea ctivation. Recent NMR studiesb yJ ohnson et al. (2000)suggested that notonlydoesthe PPARg LBD undergo ac onformational change,i ta lso changes dynamically.I nt heir study, the three-dimensional HNCO NMR cross-peaks of PPARg LBD were well resolved in thec omplexw ith af ull agonist, rosiglitazone, while the cross-peaks of theunliganded PPARg LBDwere foundto be overlapping, presumably duetothe increased mobility of thep rotein. This effect wasp ronounced in thel ower subdomain of theL BD, especially helices 3, 5, 6, 7, 11, and 12.T heyp roposed that af ulla gonist such as rosiglitazone stabilizes PPARg LBD in thec onformation favorablef or cofactor binding, whicha lsoa idsi nt he recruitment of thec ofactor.
The H/D-Ex results on PPARg LBD presented here are consistent with NMR cross-peaka nalysis performed on PPARg LBD by Johnson et al. (2000) . TheH/D-Ex results showthe lower subdomain,containing the ligandbinding pocket,t ob ee xchangingm uch faster in the ligand-free form than in thef ull agonist complexes ( Fig. 6) . The decrease in the exchange rate or protectionu ponl igand binding suggestst hat the local dynamics/mobilityo ft he protein were also decreased. Thea mide hydrogen exchange rate is mostly influenced by backbone amide hydrogen bonding; therefore, the changesi nt he rate of H/D-Ex canb ei nterpreted as conformational/dynamic perturbation upon ligand binding. Ther egions where the NMR cross-peaks were lost in the absence of rosiglitazone were in agreement with ther egions protected from H/D-Ex in theP PAR g LBD full agonist complex.
Full agonists vs. partial agonists
PPARg is the moleculart argetf or compoundss ucha s rosiglitazone and pioglitazone for thetreatment of type II diabetes .T hese molecules aref ull agonists of PPARg and servetosensitize adipose tissue to insulin.W hile these full agonists arev erye fficacious, they have undesirable side effects, including edema and weight gain (Berger et al.2 003) . Full agonists mayl ock thePPAR g intoanactive structural conformation, leading to broadg ene regulation in adipose tissue andt ot he
Figure6 . Averaged ifferencei nd euteration levels of PPARg LBDw itho rw ithout ligandso verlaido ntoathree-dimensional crystallographic structureofPPAR g LBDwithrosiglitazone (2PRG).Blueindicates that thes egment exc hanges slower with theligand present. Yellow indicatest hatt he segmente xchanges aboutt he same rate with or withoutt he ligand present. Lightg reen molecule is rosiglitazone. Gray is theregionnot coveredbythe currentexperimentalset primarilydue to thereasonmentioned in theFigure2legend. undesired side effects. Apartial agonist has been foundto have amore moderateclinical profileand an advantage as atherapeutic agent because it acts upon asubset of genes regulated by the full agonist.
Ap artial agonist,n TZDpa, perturbed the H/D-Ex of PPARg LBD farless than full agonists. nTZDpa protected helices 3a nd 6 ( Fig. 6) .T hisi sc onsistentw ith the aforementioned NMR results, which also showedv ery little change in the patterns of cross-peaks in the presence or thea bsence of nTZDpa (Berger et al.2 003) .
Whilethe crystallographic structureofPPAR g LBDinthe presence of nTZDpa is notavailable,the co-crystal structure with thep artial agonist, GW0072,i sa vailable (4PRG; Oberfielde ta l. 1999). Onei ntriguingd ifferenceb etween this structurea nd rosiglitazone-boundP PAR g LBDi st hat ac arbonylo ft he thiazolidinedioneg roup in rosiglitazone participates in ah ydrogenb onding networkw ith residues H323 (helix 5),H449(helix11),and Y473 (helix 12), while GW0072 is toof ar away to interact with theseP PAR g residues.T he lack of ah ydrogenb onding networka round helix1 2i nt he PPARg LBD-partiala gonist (GW0072) complex probably affordst he helix1 2r egiong reater mobility than theP PA R g LBD-rosiglitazonec omplex.
Antagonist GW9662
The detailed interactions betweenP PAR g and GW9662 are not well understood ( Leesnitzer et al. 2002) . Thec ocrystallographic structure of thiscomplexisnot available, andN MR studiesh aven ot yet been carried out for this complex. Co-crystals tructureso fa notherN R, estrogen receptor( ER), bound to agonist anda ntagonist, reveals that thet wo ligands bind at thes ames ite while inducing distinct conformational changes in helices 11 and 12 of theLBD (Brzozowski et al.1997 ). On theother hand,the co-crystalstructure of glucocorticoid receptor (GR) in the presence of antagonist RU486, shows that helices 11 and 12 of GR arev ery flexible (Kauppie ta l. 2003). The current H/D-Ex results presented here show that helices 11 and1 2o fP PAR g LBD remained as dynamic as the ligand free-form when complexedw ith antagonist GW9662.N oc hange in ther ate of deuterium buildup near helices 11 and12was observed (Fig.7) . This implies that, unlike full agonists, no conformationalo rd ynamic change occurs in this region upon thea ntagonist binding to PPARg .T he effects were somewhat similar to the partial agonist, nTZDpa, andv eryd ifferent from thet wo full agonistss tudied in thisw ork.
Nuclear receptor research and H/D-Ex
While structure-based drug discoveryu sing X-ray crystallography is currently them ost powerful approach for finding newdrugs, crystallization remains am ajor obstacle. Certain proteins andp rotein-ligandc omplexes are inherently noncrystallizable. ForNRresearch, crystalstructures of full-lengthNRs remain unavailable,and thenumberofcocrystal structuresi sl imited comparedw ith the number of knownd rugc andidates.
H/D-Ex can be apowerful method for theinvestigation of NR structure andf unction, ando ffers information that is complementaryt ot hatg ained throughX -rayc rystallography.I ti si ncreasingly evident that the dynamics of the LBDo fN Rs arev eryi mportant to the mechanism of NR function (Nagy and Schwabe 2004) . The H/D-Ex technology can measure the dynamics of NRs at the submolecularl evela nd in solution instead of the solid state. Thet echnology is also applicable to full-length NRs or otherligands that may not co-crystallize with their target.
Figure7. Deuterium content in each segment of PPARg LBD at 30, 100, 300, 1000, 3000, and 10,000 sec with or without ligands: ligand-free ( s ), GW9662 ( 3 ), nTZDpa ( D ), GW1929( u ), and rosiglitazone ( d ).
Onei mplication of ther esults reported here is that H/D-Ex may be able to differentiate partial agonists from full agonists using the dynamic properties of helices1 1a nd 12 of PPARg LBD.
Materials andm ethods
Materials
His-tagged PPARg LBD (33k Da, 1m g/mL, 30 m M, 20 mM Tris, 10%g lycerol, 100m MK Cl, 0.2m ME DTA, 1m MD TT) was purchased from ProteinOne. Poros 20 AL media fort he immobilized pepsin column wasp urchased from Applied Biosystems. All other reagents were obtained from Sigma.
General operation procedure A2 0-m Lr eactionv olume of H/D-exchanged protein solution was quenched by shiftingtopH2.5 with 30 m Lof2Murea and 1MTCEP at 1°C. Theq uenched solution was immediately pumped over ap epsinc olumn (104-m Lb ed volume) filled with porcine pepsin (Sigma) immobilized on Poros2 0A Lm edia at 30 mg/mLp er the manufacturer'si nstructions , with 0.05% TFA(200 m L/min) for 3min withacontemporaneous collectiono fp roteolyticp roducts by at rap column (4-m Lb ed volume).S ubsequently,t he peptide fragments were eluted from thet rap column and separated by aC 18 column (Magic C18,M ichrom BioResources,I nc.) with al inear gradient of 15%solvent Bt o40% solventBover23min (solventA, 0.05% TFAi nw ater;s olventB ,8 0% acetonitrile, 20% water, 0.01%T FA;f lowr ate 5-10 m L/min). Mass spectrometric analyses were carried out withaThermo Finnigan LCQ mass spectrometer (Thermo Electron Corp.) with capillary temperature at 200°C.
Sequence identification of pepsin-generated peptides
To quickly identify pepsin-generated peptides for each digestion condition employed, spectrald ata were acquired in datadependent MS/MS mode with dynamic exclusion.T he SEQUEST software program (Thermo Electron Corp.) wasused to identify the sequence of the dynamically selected parent peptide ions. This tentative peptide identification was verified by visual confirmation of thep arent ionc harges tatep resumed by theSEQUEST program foreach peptide.Thisset of peptides was then further examined to determine if the quality of the measured isotopic envelope of peptidesw as sufficientt oa llow accurate measurement of theg eometric centroid of isotopic envelopes on deuterated samples.
Hydrogen/deuterium exchange experiments APPAR g LBD stock solution wasprepared by mixing 20 m Lof 1mg/mL His-tagged PPARg LBD (33kDa,30 m M; ProteinOne) with 1.2 m Lo fD MSO solution( 6 10 mM ligand) and 18.8 m L of 20%glycerol.The stock solutionwas incubatedat1°Cfor at least 2hprior to the initiation of H/D-Ex experiments. An exchange reaction was initiated by diluting 4 m LofPPAR g LBD stock solution ( 6 ligand) with 16 m Lo fd euteratedb uffer (20m MT ris, 100m MN aCla tp H read 8.0). Thec oncentration of the protein was 3 m M, andthatofligandwas 60 m M(20-fold excess) in the reaction solution, which contained 0.6% DMSO, 3% glycerol, and 80% deuterated water.T he reaction mixture wasi ncubateda t2 5 6 1°Cf or varying times( 30-10,000 sec). These partially deuterateds amples were then subjected to H/DEx analysis as above,a long with control samples of nondeuterated (ran without deuteratedb uffers) and fully deuterated PPARg LBD( incubatedi n8 0m MT CEPi n8 0% D 2 Of or 2d at 37°C).
The centroids of probe peptide isotopic envelopes were measured usingt he in-house-developed program in collaboration with Sierra Analytics. The corrections for back-exchange were madeemploying methods described previously (Zhang and Smith 1993 , and m(F) are the centroidv alue of partially deuterated peptide, nondeuterated peptide, and fully deuterated peptide, respectively.M axD is them aximum deuterium incorporation calculated by subtracting the number of prolines in the third or later amino acid and two from the number of amino acids in thep eptide of interest( assuming that the first twoa mino acids cannot retain deuterons) (Bai et al. 1993) . For PPARg LBD, thed euterium recovery of af ullyd euterated sample [(m(F) -m (N)) /M axD] was averaged at 68%.
